Strain Information | |
---|---|
Image | |
BRC No. | RBRC09646 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | C57BL/6-Rftn2<tm1b(EUCOMM)Mmtm> |
Former Common name | Raftlin2 KO |
H-2 Haplotype | |
ES Cell line | EGR-G101 [C57BL/6NCr-Tg(CAG/Acr-EGFP)C3-N01-FJ002Osb] |
Background strain | C57BL/6JJcl |
Appearance | |
Strain development | Developed by Misako Matsumoto, Hokkaido University in 2013. A FRT-flanked neo cassette was removed by a CAG-Cre line. C57BL/6 background. |
Strain description | Rftn2 KO mice. Exon 2 of the Rftn2 gene was deleted. |
Colony maintenance | |
References | Raftlin Controls Lipopolysaccharide-Induced TLR4 Internalization and TICAM-1 Signaling in a Cell Type-Specific Manner. Tatematsu M, Yoshida R, Morioka Y, Ishii N, Funami K, Watanabe A, Saeki K, Seya T, Matsumoto M J. Immunol., 196(9):3865-76 (2016) 27022195 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
En2 | En2 SA (mouse En2 intron 2/exon 3 splice acceptor sequence) | 1 | En2 | ||||
Frt | yeast FRT (flippase recombination target) site | 1 | Frt | ||||
Ires | internal ribosomal entry site (EMCV) | 1 | |||||
Rftn2 | raftlin family member 2 | 1 | Rftn2 | targeted mutation 1b, Misako Matsumoto | |||
lacZ | beta-galactosidase (E. coli) | 1 | |||||
loxP | phage P1 loxP | 1 | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | yeast FRT (flipase recombination target) site, Mouse En2 intron 2/exon 3 splice acceptor sequence, Encephalomyocarditis virus (EMCV) internal ribosomal entry site (ires), E. coli lacZ, SV40 polyadenylation site, Bacteriophage P1 loxP site, mouse Rftn2 genomic DNA |
Research application | Cre/loxP system FLP/frt system Fluorescent Proteins/lacZ System |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. J. Immunol., 196(9):3865-76 (2016).The RECIPIENT shall acknowledge the EUCOMM as the provider of the knockout vector. |
Depositor | Misako Matsumoto (Hokkaido University) |
Strain Status | Frozen sperm |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |